Correlation Between Forward Pharma and Ryanair Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Forward Pharma and Ryanair Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Forward Pharma and Ryanair Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Forward Pharma A and Ryanair Holdings PLC, you can compare the effects of market volatilities on Forward Pharma and Ryanair Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Forward Pharma with a short position of Ryanair Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Forward Pharma and Ryanair Holdings.

Diversification Opportunities for Forward Pharma and Ryanair Holdings

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Forward and Ryanair is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Forward Pharma A and Ryanair Holdings PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ryanair Holdings PLC and Forward Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Forward Pharma A are associated (or correlated) with Ryanair Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ryanair Holdings PLC has no effect on the direction of Forward Pharma i.e., Forward Pharma and Ryanair Holdings go up and down completely randomly.

Pair Corralation between Forward Pharma and Ryanair Holdings

If you would invest  256.00  in Forward Pharma A on September 2, 2024 and sell it today you would earn a total of  0.00  from holding Forward Pharma A or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy0.4%
ValuesDaily Returns

Forward Pharma A  vs.  Ryanair Holdings PLC

 Performance 
       Timeline  
Forward Pharma A 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Forward Pharma A has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Forward Pharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Ryanair Holdings PLC 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Ryanair Holdings PLC are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Ryanair Holdings is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Forward Pharma and Ryanair Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Forward Pharma and Ryanair Holdings

The main advantage of trading using opposite Forward Pharma and Ryanair Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Forward Pharma position performs unexpectedly, Ryanair Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ryanair Holdings will offset losses from the drop in Ryanair Holdings' long position.
The idea behind Forward Pharma A and Ryanair Holdings PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets